Expanded access program for convalescent plasma discontinues enrollment, as FDA authorizes its emergency use.

See "EAP to EUA transition" box for physician instructions

Learn more

EAP to EUA transition

  • Enrollment and the ability to order plasma in the Mayo-led EAP have ended.
  • Physicians who need to order convalescent plasma for patients should do so using the FDA's emergency use authorization (EUA).
  • Physicians who have patients currently enrolled, consented and plasma ordered prior to September 1, 2020, in the expanded access program need to complete the required paperwork through the program physician's workflow.
  • Completing all forms is required as part of the agreement to participate in the program, statement of investigator commitments, and in compliance with federal regulations.
  • Read more about the EAP to EUA transition and the differences between the two.

Historical EAP program participation

  • Sites
  • Physicians
  • Patients
  • Infused